Literature DB >> 21836021

Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations.

Carole Fakhry1, Barbara T Rosenthal, Douglas P Clark, Maura L Gillison.   

Abstract

Human papillomavirus (HPV) is responsible for the rising incidence of oropharyngeal squamous cell cancers (OSCC) in the United States, and yet, no screening strategies have been evaluated. Secondary prevention by means of HPV detection and cervical cytology has led to a decline in cervical cancer incidence in the United States. Here, we explored an analogous strategy by evaluating associations between HPV16 infection, cytopathology, and histopathology in two populations at elevated risk for OSCCs. In the first, a cross-sectional study population (PAP1), cytology specimens were collected by means of brush biopsy from patients presenting with oropharyngeal abnormalities. In the second (PAP2), a nested case-control study, bilateral tonsillar cytology samples were collected at 12-month intervals from HIV-infected individuals. The presence of cytopathologic abnormality in HPV16-positive tonsil brush biopsies (cases) was compared with HPV16-negative samples (controls) matched on age and gender. HPV16 was detected in samples by consensus primer PCR and/or type-specific PCR. Univariate logistic regression was used to evaluate associations. In PAP1, HPV16 alone (OR: 6.1, 95% CI: 1.6-22.7) or in combination with abnormal cytology (OR: 20, 95% CI: 4.2-95.4) was associated with OSCC. In PAP2, 4.7% (72 of 1,524) of tonsillar cytology specimens from HIV-infected individuals without oropharyngeal abnormalities were HPV16 positive. Tonsillar HPV16 infection was not associated with atypical squamous cells of unknown significance (ASCUS), the only cytologic abnormality identified. Therefore, HPV16 was associated with OSCCs among individuals with accessible oropharyngeal lesions but not with cytologic evidence of dysplasia among high-risk individuals without such lesions. An oropharyngeal Pap-test equivalent may not be feasible, likely due to limitations in sampling the relevant tonsillar crypt epithelium. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21836021      PMCID: PMC3380432          DOI: 10.1158/1940-6207.CAPR-11-0284

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  31 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Trials comparing cytology with human papillomavirus screening.

Authors:  M Arbyn; G Ronco; C J L M Meijer; P Naucler
Journal:  Lancet Oncol       Date:  2009-10       Impact factor: 41.316

3.  Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group.

Authors:  J J Sciubba
Journal:  J Am Dent Assoc       Date:  1999-10       Impact factor: 3.634

4.  Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR.

Authors:  Gypsyamber D'Souza; Elizabeth Sugar; William Ruby; Patti Gravitt; Maura Gillison
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 5.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

6.  Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.

Authors:  Susanne K Kjær; Kirsten Frederiksen; Christian Munk; Thomas Iftner
Journal:  J Natl Cancer Inst       Date:  2010-09-14       Impact factor: 13.506

7.  Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations.

Authors:  Scott E Strome; Athanasia Savva; Anthony E Brissett; Bobbie S Gostout; Jean Lewis; Amy C Clayton; Renee McGovern; Amy L Weaver; David Persing; Jan L Kasperbauer
Journal:  Clin Cancer Res       Date:  2002-04       Impact factor: 12.531

8.  Incidence of cervical squamous intraepithelial lesions in HIV-infected women.

Authors:  T V Ellerbrock; M A Chiasson; T J Bush; X W Sun; D Sawo; K Brudney; T C Wright
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

9.  Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study.

Authors:  Susanne K Kjaer; Adriaan J C van den Brule; Gerson Paull; Edith I Svare; Mark E Sherman; Birthe L Thomsen; Mette Suntum; Johannes E Bock; Paul A Poll; Chris J L M Meijer
Journal:  BMJ       Date:  2002-09-14

10.  Second edition of 'The Bethesda System for reporting cervical cytology' - atlas, website, and Bethesda interobserver reproducibility project.

Authors:  Ritu Nayar; Diane Solomon
Journal:  Cytojournal       Date:  2004-10-21       Impact factor: 2.091

View more
  49 in total

Review 1.  Epidemiology and clinical aspects of HPV in head and neck cancers.

Authors:  Anil K Chaturvedi
Journal:  Head Neck Pathol       Date:  2012-07-03

Review 2.  Discussing the diagnosis of HPV-OSCC: common questions and answers.

Authors:  Carole Fakhry; Gypsyamber D'Souza
Journal:  Oral Oncol       Date:  2013-07-19       Impact factor: 5.337

Review 3.  Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.

Authors:  Julia M L Brotherton; Mark Jit; Patti E Gravitt; Marc Brisson; Aimée R Kreimer; Sara I Pai; Carole Fakhry; Joseph Monsonego; Silvia Franceschi
Journal:  Int J Cancer       Date:  2016-03-22       Impact factor: 7.396

4.  Nonkeratinizing Squamous Cell Carcinoma In Situ of the Upper Aerodigestive Tract: An HPV-Related Entity.

Authors:  Lingxin Zhang; James S Lewis; Samir K El-Mofty; Manoj Gandhi; Rebecca D Chernock
Journal:  Head Neck Pathol       Date:  2016-08-04

Review 5.  Reducing HPV-associated cancer globally.

Authors:  Douglas R Lowy; John T Schiller
Journal:  Cancer Prev Res (Phila)       Date:  2012-01

Review 6.  The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.

Authors:  Theresa Guo; David W Eisele; Carole Fakhry
Journal:  Cancer       Date:  2016-05-06       Impact factor: 6.860

Review 7.  HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection.

Authors:  Mary Roz Timbang; Michael W Sim; Arnaud F Bewley; D Gregory Farwell; Avinash Mantravadi; Michael G Moore
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

8.  Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007.

Authors:  George Kurdgelashvili; Graça M Dores; Samer A Srour; Anil K Chaturvedi; Mark M Huycke; Susan S Devesa
Journal:  Cancer       Date:  2013-04-11       Impact factor: 6.860

Review 9.  Epidemiology of HPV-associated oropharyngeal cancer.

Authors:  Kristen B Pytynia; Kristina R Dahlstrom; Erich M Sturgis
Journal:  Oral Oncol       Date:  2014-01-22       Impact factor: 5.337

10.  Transforming Cancer Prevention through Precision Medicine and Immune-oncology.

Authors:  Thomas W Kensler; Avrum Spira; Judy E Garber; Eva Szabo; J Jack Lee; Zigang Dong; Andrew J Dannenberg; William N Hait; Elizabeth Blackburn; Nancy E Davidson; Margaret Foti; Scott M Lippman
Journal:  Cancer Prev Res (Phila)       Date:  2016-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.